Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Diageo plc (ADR) (DEO): Is The Company an Exciting Emerging Market Play?

Diageo plc (ADR)(NYSE:DEO)LONDON — While crippling austerity in Europe and fiscal obstacles could put the brake on growth rates there, in developing regions a backdrop of accommodative central bank action, elevated commodity prices, and rising personal affluence levels have created an environment of exceptional commercial opportunity.

The divergence between the growth prospects of traditional and developing markets is borne out by latest International Monetary Fund’s (IMF) growth projections, which expects developing nations and emerging markets to expand 5.3% and 5.7% in 2013 and 2014, respectively. By comparison, it anticipates that the U.S. economy will rise 1.9% this year and 3% in 2014, while eurozone GDP is forecast to dip 0.3% in 2013 before rebounding just 1.1% next year.

Bubbly activity in these developing geographies can create large opportunities for many London-listed firms. Today, I am looking at Diageo plc (ADR) (NYSE:DEO) and assessing whether its operations in these regions are likely to underpin solid earnings growth.

Developing market sales continue to grow
Diageo plc (ADR) (NYSE:DEO) announced earlier this month that organic net sales rose 5% in the nine months to the end of March, with volumes increasing 1% over the period. The firm, whose portfolio of premium drinks brands includes megabrands Guinness, Smirnoff, Johnnie Walker, and Baileys, holds excellent pricing power, which can allow it to raise turnover even in times of volume pressure.

Organic growth in Latin America and the Caribbean came in at 14% in June-March, while sales in Africa, Eastern Europe, and Turkey rose 9% and growth in the Asia-Pacific clocked in at 4%. In its traditional markets, meanwhile, North American organic growth came in at a respectable 6% for June-March, although sales in Western Europe dipped 4%.

Although emerging market growth moderated from earlier months in December-March, the third quarter is a small quarter for the firm and it was beset by technical issues such as shipment phasing in Columbia and Venezuela. It also advised of solid spirits growth in Africa and market share gains in Asia-Pacific during the period, tempering fears that it was running out of steam in developing markets.

Diageo plc (ADR) (NYSE:DEO) remains locked in battle in its bid to acquire a 53.4% stake in India’s United Spirits, boosting its holding from 27.4% at the present time. However, the deal is tipped by many to fail as the Indian distillers’ price has shot higher since Diageo purchased its initial stake in November and announced plans to launch a mandatory offer for the remaining 26%. Diageo plc (ADR) (NYSE:DEO) has failed to increase its offer, which expires today.

However, Diageo plc (ADR) (NYSE:DEO) still has effective control of the firm — its stake enabling it to appoint the chief executive and chief financial officers and influence board appointments — and still gives it a chunky holding in what is a massive player in the Indian spirits market.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.